Ajay Singla, MD, has joined The University of Toledo Medical Center, Toledo, OH, and separately, David M. Barrett, MD, has been elected to the board of directors of ProUroCare Medical Inc. in Minneapolis.
UCSF Health performs 150th robotic focal HIFU procedure
UCSF is West Coast leader for the innovative, minimally invasive treatment for prostate cancer patients.
How APPs can bridge the gap in urologist shortages
In this episode, Janelle Bunce, PA-C, highlights the role that advanced practice providers can play in filling the gaps created by the growing workforce shortages in urology.
Enfortumab vedotin plus pembrolizumab improves survival in frontline urothelial cancer
The EV-302 trial is the confirmatory trial for the FDA’s accelerated approval of pembrolizumab plus enfortumab vedotin for the first-line treatment of patients with locally advanced or metastatic urothelial carcinoma.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
How to bill for PCNL using existing and new access
Proper coding for percutaneous nephrolithotomy includes code 50081.
Liposomal tacrolimus shows promise for hemorrhagic cystitis
Liposomal tacrolimus led to improvements in hematuria, bleeding sites on cystoscopy, microscopic urine analysis for red blood cells, and urinary symptoms.
2 Clarke Drive Cranbury, NJ 08512